The decision expands access to one of the most critical tools in the fight against poliovirus type 2 outbreaks, supporting more sustainable outbreak control and reinforcing global immunization efforts ...

The development expands BE's WHO-qualified manufacturing scope beyond phase I, under which the company received PQ in June 2024 for drug product manufacturing using externally supplied drug substance.

Africa's engagement with global vaccine supply over the past five years has shown that access to vaccines and biologics is shaped less by goodwill or financing alone.Vaccine sovereignty in Africa is ...

With this, the Department of Health in Negros Island Region (DOH-NIR) has praised and signified its intention to mirror this province’s best practices on supply chain management. DOH-NIR Regional ...

This history of rapid acceleration suggests that Eli Lilly is primed for another massive breakout as new catalysts emerge.

Biological E Ltd receives full WHO approval for nOPV2 polio vaccine, enhancing global outbreak response and manufacturing capabilities.

Biological E. has received phase II pre-qualification of the World Health Organisation for its novel oral polio vaccine type ...

In today’s issue: The winner and loser of today’s congressional health affordable hearing. A bipartisan agreement to reveal ...

Meet the systems architect ensuring resilient manufacturing, stable supply chains, and the unseen infrastructure behind daily life.

The push to bring manufacturing back to America sits at the top of President Donald Trump’s agenda. He has vowed to ...

Hyderabad based Biological E. Limited (BE) on Thursday announced a major milestone in the global fight against polio, with the World Health Organization (WHO) granting Phase II Pre-Qualification (PQ) ...